Pfizer’s BRAFTOVI combo doubles progression-free survival in aggressive colorectal cancer trial
The results confirm the study’s primary endpoint of objective response rate and now deliver a striking signal in progression-free survival
The results confirm the study’s primary endpoint of objective response rate and now deliver a striking signal in progression-free survival
This marks one of the most closely watched oncology readouts at this year’s medical congress
The programme is being implemented in collaboration with Grow Well Foundation and is expected to expand in a phased manner
The programme aims to provide critical healthcare services to approximately 4 lakh people in remote and resource-scarce communities
Under the agreement, healthcare professionals in the country will gain access to C2N’s PrecivityAD2 blood test
Emcure to distribute Roche's kidney transplant and anemia drugs in India
Both non-transfusion-dependent and transfusion dependent cohorts met their respective primary and secondary endpoints
The paper highlights how conditions common across India—including anemia, inherited hemoglobin disorders, and glucose-6-phosphate dehydrogenase (G6PD) deficiency—can significantly distort HbA1c readings
The trial supports the potential for another chemotherapy backbone option that may be paired with encorafenib plus cetuximab in this patient population
The state-of-the-art laboratory opens at the Corewell Health Southfield Center in early 2027
Subscribe To Our Newsletter & Stay Updated